Status:

UNKNOWN

Study of Motor Inhibition in Parkinson's Disease and Focal Hand Dystonia

Lead Sponsor:

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Conditions:

Parkinson Disease

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The current research protocol aims at studying preparatory inhibition in two populations of patients suffering from movement disorders. First, in PART 1, we will work with Parkinson's disease (PD) pat...

Detailed Description

Any movement requires some planning, relying substantially on neural cells in the frontal cortex connected with spinal circuits, which themselves help regulating muscle activity. These corticospinal p...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Diagnosis of idiopathic PD (according to the United Kingdom PD Society Brain Bank Clinical Diagnostic Criteria) (for PD participants)
  • Good response to levodopa (improvement on the UPDRS-III scale) (for PD participants)
  • Hoehn and Yahr stage: \< or = 3 (for PD participants)
  • Absence of severe tremor (for PD participants)
  • Absence of dyskinesia (for PD participants)
  • Between 18 and 85 years old (for all participants)
  • Normal or corrected-to-normal vision (for all participants)
  • Exclusion Criteria (for all participants):
  • Severe cognitive impairment (Score of \<21/30 with the Montreal Cognitive Assessment (MoCA))
  • MRI-incompatible metal device in the body
  • History of major psychiatric or neurological disorder (other than PD for the patient group)
  • Personal or family history of epilepsy
  • History of substance use disorder (except nicotine)
  • Untreated or unstable medical conditions that could interfere with cognitive functioning
  • Undergoing any drug treatment that can significantly alter task performance or neural activity

Exclusion

    Key Trial Info

    Start Date :

    July 31 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 23 2023

    Estimated Enrollment :

    200 Patients enrolled

    Trial Details

    Trial ID

    NCT05209516

    Start Date

    July 31 2018

    End Date

    April 23 2023

    Last Update

    January 26 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Cliniques universitaires Saint-Luc

    Brussels, Belgium, 1200